12:00 AM
 | 
Apr 18, 2011
 |  BC Week In Review  |  Company News  |  Deals

Axcan, Mpex deal

Specialty pharma Axcan will acquire infectious disease company Mpex for an undisclosed upfront payment, plus milestones. Axcan will gain Mpex's Aeroquin, which is in Phase III testing to treat pulmonary infections in cystic fibrosis...

Read the full 156 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >